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Hereditary hemolytic anemia comprises a group of disorders in which red blood cells are 
destroyed faster than they are produced in the bone marrow; various hereditary factors 
can cause this condition, including production of defective Hb and erythrocyte membrane. 
Recently, we identified Hb Koriyama, a rare Hb variant that was undetectable in Hb elec-
trophoresis and stability tests, in a patient with severe hemolytic anemia. This is the first 
study to show the nucleotide-level sequence variations in Hb Koriyama. On the basis of 
our results, we conclude that unstable Hb may not be detectable by conventional Hb elec-
trophoresis or stability tests. Thus, we suggest further genetic workup in cases of unex-
plained hereditary hemolytic anemia.
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INTRODUCTION
Hereditary hemolytic anemia comprises a group of disorders in 
which red blood cells (RBCs) are destroyed faster than they are 
produced in the bone marrow; various hereditary factors can 
cause this condition, including production of defective Hb and 
erythrocyte membrane. Unstable Hb, which includes defective 
hemoglobin molecules, should be considered as an important 
causative factor in patients with hereditary nonspherocytic he-
molytic anemia [1]. Unstable Hb may be detected by the pres-
ence of an additional abnormal band in Hb electrophoresis or 
by demonstration of increased instability in Hb stability tests. 
However, the hemoglobin may be missed unless it is sufficiently 
stable to be detected by these methods [2-4]. Therefore, in pa-
tients showing hereditary nonspherocytic hemolytic anemia, fur-
ther genetic workup for identification of unstable Hb is required 
even if the patients show normal results in Hb electrophoresis or 
stability tests [5].
  Recently, we identified Hb Koriyama, a rare Hb variant that 
was undetectable in Hb electrophoresis and stability tests, in a 
patient with severe hemolytic anemia. Hb Koriyama is a highly 
unstable Hb variant and is formed by the tandem insertion of a 
5-residue segment in the FG region of the Hb β-chain. The mo-
lecular structure of this variant was first modeled at the peptide 
sequence level and further presumptive changes were intro-
duced in the nucleotide sequence [6] Here, we present the first 
case report confirming a change in the nucleotide sequence of 
Hb Koriyama.
 
CASE REPORT
A 6-yr-old girl was referred for a genetic workup of unexplained 
severe hereditary hemolytic anemia. She was born at 37 weeks’ 
gestational age at a local hospital, and her birth weight was 2,750 
g; no morphological abnormality was observed at birth. She de-
veloped an icteric appearance with a total bilirubin level of 13.0 Park S, et al.
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mg/dL on the second day after birth; the condition was success-
fully treated using phototherapy. At 3 months of age, she pre-
sented with sudden-onset hematuria and pallor. Laboratory test 
results showed severe hemolytic anemia with hyperbilirubine-
mia. The initial laboratory test results were as follows: Hb, 4.4 g/
dL; hematocrit, 12.2%; reticulocyte count, 12.2%; total bilirubin, 
5.8 mg/dL; direct bilirubin, 1.8 mg/dL; aspartate transaminase, 
65 IU/L; and alanine transaminase, 15 IU/L. She received regu-
lar blood transfusions to raise her Hb level.
  All tests for evaluating the peripheral blood-cell parameters 
were performed after the patient was referred to our hospital: 
Hb, 7.2 g/dL; mean corpuscular volume (MCV), 89.7 fL; mean 
corpuscular Hb (MCH), 29.6 pg; hematocrit, 26.1%; reticulocyte 
count, 29.0%; red cell distribution width (RDW), 35.3%; and 
nucleated RBC count, 143/100 white blood cells (WBCs). Pe-
ripheral blood smear showed normocytic and normochromic 
RBCs with severe anisocytosis, mild polychromasia, nucleated 
RBCs, and moderate poikilocytosis with elliptocytes, acantho-
cytes, and burr cells. To rule out hereditary spherocytosis, we 
performed an osmotic fragility test and erythrocyte membrane 
protein analysis; we obtained normal results for both these tests. 
For the latter, the levels of erythrocyte membrane proteins such 
as spectrin, ankyrin, band 3, and proteins 4.1 and 4.2 were ana-
lyzed using sodium dodecyl sulfate polyacrylamide gel electro-
phoresis. Hb electrophoresis was performed using a capillary 
electrophoresis system (Capillarys; Sebia, Lisses, France); the 
results showed low HbA (92.7%) levels, normal HbA2 (3.2%) 
levels, and elevated HbF (4.1%) levels (Fig. 1). Instability and 
isopropanol precipitation tests showed normal results.
  The β- and α-globin genes (HBB and HBA) were analyzed to 
rule out the possibility of hemoglobinopathy. For this analysis, 
first, the entire HBB sequences were analyzed. Genomic DNA 
was extracted from blood using Puregene DNA isolation kit 
(Gentra Systems, Inc., Minneapolis, MN, USA). We performed 
gene-specific PCR and direct sequencing using a DNA analyzer 
(3730xl; Applied Biosystems, Foster City, CA, USA). Second, de-
letions or duplications in the β- and α-globin gene clusters were 
screened using a multiplex ligation-dependent probe amplifica-
tion (MLPA) kit (P102-B1/P140-B2; MRC-Holland, Amsterdam, 
the Netherlands).
  Gene sequence analysis revealed a heterozygous mutation, 
HBB c.280_294dup, p.(Cys94_His98)dup. We assume that this 
mutation led to the duplication of 5 amino acids from codons 94 
to 98 (Fig. 2). The aberrant amino acid sequence created by 
this mutation was identical to that of Hb Koriyama, although 
Kawata et al. [6] had originally described the sequence as an 
insertion of 5 amino acids (Leu-His-Cys-Asp-Lys) between co-
dons 96 and 97 (Fig. 3). Any large deletion or duplication was 
not detected in both globin genes on MLPA test.
Fig. 1. Results of the capillary zone electrophoresis showing de-
creased HbA levels (92.7%; reference interval, 96.8-97.8%), nor-
mal HbA2 levels (3.2%; reference interval, 2.2-3.2%), and increased 
HbF levels (4.1%; reference interval, ≤ 0.5%).
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Fig. 2. Detailed characterization of the 15-bp duplication mutation identified in this study and the repeat sequence that flanks the duplication 
segment.
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DISCUSSION
Our case is the second report of Hb Koriyama in the literature; 
the first one was published by Kawata et al. In the study by 
Kawata et al. [6], the patient had severe chronic hemolytic ane-
mia, splenomegaly, and required blood transfusion. Interestingly, 
the isopropanol test for their patient yielded positive results and 
thus, unstable Hb could be suspected easily; however, the iso-
propanol test was negative in our patient. Therefore, the Hb sta-
bility test cannot be relied upon to produce repeatable results 
for certain unstable Hb variants, and a negative result in this test 
does not necessarily exclude further genetic workup.
  More than 185 unstable variants of both α- and β-globin chains, 
which produce varying degrees of hemolytic anemia (http://glo-
bin.cse.psu.edu/), have been identified [2-4]. Many unstable 
variants are associated with mild hemolytic features with minimal 
or even no anemia in the steady state. Furthermore, extremely 
unstable Hb is not detectable by the commonly used methods 
of Hb separation, as in the case of our patient [7]. Therefore, 
unstable Hb should be considered as a possible cause when 
unexplained hemolytic anemia i s diagnosed in patients.
  By performing an amino acid analysis, Kawata et al. [6] showed 
that a 5-amino acid residue segment, which included cysteine 
at position 93, was repeated in tandem in the abnormal β chain. 
However, nucleotide sequence changes leading to the produc-
tion of this abnormal Hb were not mentioned in their original 
study. Our results show that duplication of the 15-nucleotide 
segment from positions 280 to 294 can result in a 5-residue du-
plication seen in Hb Koriyama. Two 8-bp identical AGCTGCAC 
sequences that are present on both sides of the 280–294-bp 
segment may be a potential core of a replication misalignment 
event. It can result in either a 15-bp tandem duplication, such 
as that observed in our patient and Hb Koriyama, or a 15-bp 
deletion, such as in Hb Gun Hill [8].
  In conclusion, our study is the first case of Hb Koriyama where 
the sequence change has been identified at the nucleotide level. 
It has to be emphasized that unstable Hb may not be detectable 
by conventional Hb electrophoresis or stability tests. Thus, ge-
netic workup should be performed in cases of unexplained he-
reditary hemolytic anemia.
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Fig. 3. Characteristics of aberrant amino acid sequences observed 
from the 15-bp duplication, and comparison of this duplication mu-
tation with Hb Gun Hill, Hb Fairfax, and Hb Koriyama.
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